← Trials/Trial dossier/NCT01237314

REACT2

Completed

The Impact of Food on Blood Sugar in People With Type 2 Diabetes

Evaluation of the Glycemic Impact of Food in Patients With Type 2 Diabetes Taking Glargine and/or Exenatide

Lead sponsor

HealthPartners Institute

Asset

Exenatide

GLP-1 agonist

Listed sites

Recruiting sites

—

Enrollment

actual

Study population

Type 2 diabetes

Key I/E criterion

—

Primary endpoint

•Postprandial glucose (CGM time-above-range)

Footprint

Where this trial recruits

Site locations as reported to ClinicalTrials.gov. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT01237314

Org study ID04037-10-C

Timeline

Milestones

Study first posted2010-11-09estimated

Last update posted2015-12-02estimated

Study start2010-11 (month precision)

Primary completion2013-05actual (month precision)

Study completion2013-05actual (month precision)

Assets

Investigational agents

Exenatide

Study populations

Who this study enrolls

Type 2 diabetes

Eligibility

Who can enroll

Minimum age18 Years

Maximum age75 Years

SexAll

Healthy volunteersNot accepted

Sampling methodNon probability sample

Study population text

Participants in Clinical Trials Study NCT01089569

Inclusion criteria

•Study participants who are consented for the primary study and have not yet done the baseline CGM data collection at week -2-0.

Exclusion criteria

•Study participants who are unable to complete the baseline CGM data collection at week -2-0.

•Study participants who are allergic to or have a food intolerance to any of the foods in the fixed meal

Endpoints (1)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

Glycemic / diabetes

1 endpoint

Primary/protocol endpoint

4-hour glycemic response at 3 time points

Time frame:4 hours

Postprandial glucose

descriptive, improvement

componentsCGM time-above-range

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 1, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 1, 2026 snapshot.